The Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of Rice University’s health and medical technology discoveries into cures, today announced the addition of David Allison to its external advisory board.
Rice continues to stand out for its academic excellence with several graduate programs earning high marks in the latest edition of U.S. News & World Report’s “Best Graduate Schools” rankings.
A team of researchers from the Rice Biotech Launch Pad has developed an implantable “cytokine factory” that safely triggers potent immune responses against hard-to-treat cancers, including metastatic melanoma, pancreatic and colorectal tumors.
Pranai Reddy, a senior studying business management, biochemistry and entrepreneurship, has spent his time at Rice University figuring out how to improve the usability in prosthetic hands and how to give students a hands-on learning experience in venture capital.
An interdisciplinary group of researchers at Rice University has developed an innovative RNA “barcoding” method to track these genetic exchanges in microbial communities, providing new insights into how genes move across species.
The Rice Biotech Launch Pad is launching a Rice Venture Creation Fellowship, a program providing recent doctoral graduates passionate about innovation and startup development with training and resources.
Through an eight-week immersive experience, Rice students observed complex clinical environments at Texas Children’s Hospital and the Texas Heart Institute, identifying unmet health care needs and exploring solutions with a human-centered approach.
A team of researchers at Rice has developed an innovative AI-enabled, low-cost device that will make flow cytometry ⎯ a technique used to analyze cells or particles in a fluid using a laser beam ⎯ affordable and accessible.
Rice neuroscientist Valentin Dragoi and Ariana Andrei from the Houston Methodist Research Institute developed a detailed, step-by-step guide for deploying optogenetics in nonhuman primates, providing critical guidance for researchers working to advance understanding of the brain’s complex networks and their relationship with behavior.
Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand with focused ultrasound can significantly reduce tumor size and burden in prostate cancer models, according to a new study published in Advanced Science by researchers at Rice and Vanderbilt.
As a partner institution of the Center for Clinical and Translational Sciences at UTHealth Houston, Rice has received approximately $1.69 million in grant funding to support pilot projects, student training and collaborative research in bioengineering, informatics, team science and related areas.
The Rice lab of bioengineer Gang Bao and collaborators at Baylor College of Medicine have developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic disorders in this vital organ as well as in other organs and tissues.
Rice computer scientist Lydia Kavraki has been elected to the National Academy of Engineering, one of the highest professional honors accorded to an engineer, for her work on “developing randomized motion-planning algorithms for robotics and robotics-inspired methods in biomedicine.”